215 related articles for article (PubMed ID: 26414087)
1. Societal costs of diabetes mellitus in Denmark.
Sortsø C; Green A; Jensen PB; Emneus M
Diabet Med; 2016 Jul; 33(7):877-85. PubMed ID: 26414087
[TBL] [Abstract][Full Text] [Related]
2. Costs of diabetes and its complications in Poland.
Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
[TBL] [Abstract][Full Text] [Related]
3. Short-term societal economic burden of first-incident type 2 diabetes-related complications - a nationwide cohort study.
Kjellberg J; Tikkanen CK; Bagger M; Gæde P
Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):577-586. PubMed ID: 33054434
[TBL] [Abstract][Full Text] [Related]
4. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
5. The impact of diabetes mellitus on healthcare costs in Italy.
Giorda CB; Manicardi V; Diago Cabezudo J
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
[TBL] [Abstract][Full Text] [Related]
6. Cost of illness of atrial fibrillation: a nationwide study of societal impact.
Johnsen SP; Dalby LW; Täckström T; Olsen J; Fraschke A
BMC Health Serv Res; 2017 Nov; 17(1):714. PubMed ID: 29126415
[TBL] [Abstract][Full Text] [Related]
7. The societal cost of schizophrenia in Sweden.
Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
[TBL] [Abstract][Full Text] [Related]
8. Economic Costs Attributable to Diabetes in Each U.S. State.
Shrestha SS; Honeycutt AA; Yang W; Zhang P; Khavjou OA; Poehler DC; Neuwahl SJ; Hoerger TJ
Diabetes Care; 2018 Dec; 41(12):2526-2534. PubMed ID: 30305349
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
Salman RA; AlSayyad AS; Ludwig C
BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
[TBL] [Abstract][Full Text] [Related]
10. Attributable societal costs of first-incident obesity-related cardiovascular comorbidities in Denmark.
Kjellberg J; Tikkanen CK
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):673-681. PubMed ID: 33794723
[No Abstract] [Full Text] [Related]
11. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.
Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž
Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205
[TBL] [Abstract][Full Text] [Related]
12. Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.
Sortsø C; Komkova A; Sandbæk A; Griffin SJ; Emneus M; Lauritzen T; Simmons RK
Diabetologia; 2018 Jun; 61(6):1306-1314. PubMed ID: 29549417
[TBL] [Abstract][Full Text] [Related]
13. Economic Costs of Diabetes in the U.S. in 2017.
American Diabetes Association
Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
[TBL] [Abstract][Full Text] [Related]
14. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.
Diabetes Care; 1998 Feb; 21(2):296-309. PubMed ID: 9539999
[TBL] [Abstract][Full Text] [Related]
15. Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen.
Gundgaard J; Christensen TE; Thomsen TL
Prim Care Diabetes; 2010 Oct; 4(3):165-72. PubMed ID: 20452847
[TBL] [Abstract][Full Text] [Related]
16. Health economic changes as a result of implementation of targeted therapy for metastatic renal cell carcinoma: national results from DARENCA study 2.
Soerensen AV; Donskov F; Kjellberg J; Ibsen R; Hermann GG; Jensen NV; Fode K; Geertsen PF
Eur Urol; 2015 Sep; 68(3):516-22. PubMed ID: 25533417
[TBL] [Abstract][Full Text] [Related]
17. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach.
Tingstedt B; Andersson E; Flink A; Bolin K; Lindgren B; Andersson R
World J Surg; 2011 Oct; 35(10):2298-305. PubMed ID: 21850604
[TBL] [Abstract][Full Text] [Related]
19. Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.
Vadstrup K; Alulis S; Borsi A; Elkjaer Stallknecht S; Nielsen A; Rikke Jørgensen T; Wennerström C; Qvist N; Munkholm P
Scand J Gastroenterol; 2020 Jan; 55(1):41-46. PubMed ID: 31960726
[No Abstract] [Full Text] [Related]
20. Overweight and obesity on the island of Ireland: an estimation of costs.
Dee A; Callinan A; Doherty E; O'Neill C; McVeigh T; Sweeney MR; Staines A; Kearns K; Fitzgerald S; Sharp L; Kee F; Hughes J; Balanda K; Perry IJ
BMJ Open; 2015 Mar; 5(3):e006189. PubMed ID: 25776042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]